Aller au contenu principal
Accès ouvert déclaré 2026 other

Figure 3 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

PDAC cell lines with acquired resistance to pharmacologic inhibitors of RAS exhibit enhanced macropinocytosis. A, Schematic diagram showing the experimental design for generating cell lines with acquired resistance to MRTX1133 (G12Di) and RMC7797 (RASi). B, Representative images of macropinosomes labeled with FITC–dextran (green) and nuclear DAPI stain (blue) in indicated parental or MRTX849- (G12Ci-R), MRTX1133- (G12Di-R), or RMC7797-resistant (RASi-R) KRAS-mutant PDAC cells. Images are representative of 10 fields of view analyzed in each of three independent experiments. Scale bars, 20 μm. C, Quantification of relative macropinocytic (MP) index, with each individual data point representing one field containing at least 10 analyzed cells. Data are presented as the mean ± SD of one experiment that is representative of three independent experiments. ****, ρ < 0.0001, by the unpaired Student t test, comparing against the respective parental cell line. D, Macropinocytic uptake of TMR–dextran was measured by MFI via flow cytometry in indicated parental or MRTX849- (G12Ci-R), MRTX1133- (G12Di-R), or RMC7797-resistant (RASi-R) KRAS-mutant PDAC cell lines. Data are presented as the mean ± SEM of three independent experiments. **, ρ < 0.01 and ***, ρ < 0.001 by the unpaired Student t test, comparing against the respective parental cell line. E, Representative images of macropinosomes labeled with FITC–dextran (green) and nuclear DAPI stain (blue) in indicated treatment-naïve (naïve) or RMC7797-resistant (resistant) tumor-derived KPC cells. Images are representative of 10 fields of view analyzed in each of three independent experiments. Scale bars, 20 μm. F, Macropinocytic uptake of TMR–dextran was measured by MFI via flow cytometry in indicated treatment-naïve (naïve) or RMC7797-resistant (resistant) tumor-derived KPC cell lines. Data are presented as the mean ± SEM of three independent experiments. **, ρ < 0.01 by nested two-way ANOVA. G, Relative levels of selected macropinocytosis-related proteins in PANC-1 cells following 24 or 168 hours of RASi treatment, as well as in a RASi-R cell line. Line color represents the direction of change from 24 hours RASi treatment to RASi resistance, and line transparency represents the magnitude of change. Dex, dextran; MFI, median fluorescence intensity. [A, Created in BioRender. Robb, R. (2026) https://BioRender.com/rx7i90i.]

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Figure 3 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling
Date Crossref
28/07/2026
Éditeur
American Association for Cancer Research (AACR)
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.